Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Monoclonal Antibodies
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
Roles of Retromer Complex in Development
Genetic Variants Influencing Response to Vitamin D in Colorectal Chemoprevention
Role of H. pylori Outer Membrane Proteins in Colonization and Host Response
Effects of Parkinson's Disease on Perception, Cognition, and Gait
Recently added grants:
Combination treatment of ischemic stroke with perlecan DV and neural stem cells
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
Host genetic determinants of diversity in viral-induced neuropathology
Development of cellular HTS for 20S proteasome enhancers
Repair of neurological disorders through RNA editing
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067938-000
Application #
3614575
Study Section
Project Start
1986-09-18
Project End
Budget Start
1986-09-18
Budget End
1987-03-31
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant